
This section contains 15 True/False Questions from Basics of transfusion medicine which should be known to Hematologists.
This Q are to be answered as true and False.
Marking > 1 mark for Correct response and 0 for wrong response.
An Interactive Social media platform for hematologists and aspiring hematologists !
This section contains 15 True/False Questions from Basics of transfusion medicine which should be known to Hematologists.
This Q are to be answered as true and False.
Marking > 1 mark for Correct response and 0 for wrong response.
Sir pls explain question 10
Yes the explanation indicates answer as true and it’s given false
Sir regarding question 14- leukoreduction is mostly effective against febrile non hemolytic transfusion reaction, but for CMV protection much more reduction is needed. So “All” word seems to be quite contrary.
Leuckoreduction to the recomended level ( < 5 x 10(6) WBC/RBC unit reduces the risk of FNHTR as well as CMV hance leukoreduced products are given to those at risk of CMV infection as neonates, transplant patients and patients on chemotherapy.
Yes, explanation is correct… Just the answer was wrong which has now been rectified
Thanks for bringing into notice.